Arnuity ellipta and Centrum drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Arnuity ellipta and Centrum. Common interactions include joint injury among females and anxiety among males.
The phase IV clinical study analyzes what interactions people who take Arnuity ellipta and Centrum have. It is created by eHealthMe based on reports of 10 people who take Arnuity ellipta and Centrum from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10 people who take Arnuity ellipta and Centrum together, and have interactions are studied.
What is Arnuity ellipta?
Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 2,725 Arnuity ellipta users for its effectiveness, alternative drugs and more.
What is Centrum?
Centrum has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 33,443 Centrum users for its effectiveness, alternative drugs and more.
Number of Arnuity ellipta and Centrum reports submitted per year:
Common Arnuity Ellipta and Centrum drug interactions by gender *:
- Joint injury
- Panic attack
- Productive cough
- Abdominal pain upper
- Back disorder
- Adverse drug reaction
- Drug ineffective
Common Arnuity Ellipta and Centrum drug interactions by age *:
- Joint injury
- Productive cough
Common conditions people have *:
- Hyperkalemia (damage to or disease of the kidney): 5 people, 50.00%
- Skin Candida (fungal infection of skin): 1 person, 10.00%
- High Blood Cholesterol: 1 person, 10.00%
- Depression: 1 person, 10.00%
- Diabetes: 1 person, 10.00%
- Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 10.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 10.00%
- Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 10.00%
- Hair Loss: 1 person, 10.00%
- High Blood Pressure: 1 person, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Arnuity ellipta and Centrum?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Arnuity ellipta and Centrum:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Arnuity ellipta interactions:
Browse all interactions between Arnuity ellipta and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Centrum interactions:
Browse all interactions between Centrum and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone furoate and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Arnuity ellipta and Centrum, respectively), and Arnuity ellipta and Centrum (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Arnuity ellipta and Centrum.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nifedipine and Tyvaso drug interaction - 4 seconds ago
- Gravol vs. Omeprazole - 13 seconds ago
- How effective is Quercetin-3-Rutinoside for Allergies? - 17 seconds ago
- Dupuytren'S Contracture and drugs of ingredients of hydroxyzine pamoate - 18 seconds ago
- Metformin and Cataract Subcapsular - 32 seconds ago
- Polyethylene Glycol 3350 vs. Probiotics - a minute ago
- Korlym and Prothrombin Time Abnormal - a minute ago
- Synthroid and Throat Tightness - a minute ago
- Tysabri and Nucleated Red Cells - 2 minutes ago
- Protonix and Cyclic Vomiting Syndrome - 2 minutes ago